National Trends and Outcomes of Tricuspid Valve Surgery with Concomitant Mitral Valve Surgery: Results From a Ten-year Analysis of the National Inpatient Sample Database Article

Full Text via DOI: 10.1016/j.cpcardiol.2022.101523 Web of Science: 000911608400001

Cited authors

  • Sagheer S, Sohail AH, Shahjehan RD, Zaidi SH, Khan UA, Arshad HB, Sheikh A, Paul A, Wasty N

Abstract

  • According to an estimate, 20% of patients with heart valve disease have multivalve involvement necessitating combined valve surgery. There is a dearth of data about the clinical outcomes of patients with combined mitral and tricuspid valve disease who go through tricuspid valve surgery with concomitant mitral valve replacement or repair. We utilized National Inpatient Sample (NIS) between January 1, 2004, and December 31, 2014, to analyze the outcomes of patients who underwent tricuspid valve surgery with either mitral valve replacement or repair. We identified 21,141 weighted hospitalizations for combined TVS with MVr (TVS/MVr) or TVS with MVR (TVS/MVR). The overall inpatient mortality in the TVS/MVR cohort was higher than in the TVS/MVr cohort (7.36% vs 5.33%, P < 0.01). There was a trend toward decreased mortality over the years in the TVS/ MVr cohort (P = 0.04) while mortality remained unchanged in the TVS/MVR cohort (P = 0.88). Overall, the TVS/MVr cohort had better clinical outcomes profile compared with TVS/MVR cohort. (Curr Probl Cardiol 2023;48:101523.)

Publication date

  • 2023

Published in

International Standard Serial Number (ISSN)

  • 0146-2806

Number of pages

  • 16

Volume

  • 48

Issue

  • 3